Live Breaking News & Updates on Congenital Anomalies
Stay updated with breaking news from Congenital anomalies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ProKidney (NASDAQ:PROK – Get Free Report) and Cabaletta Bio (NASDAQ:CABA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Volatility and Risk ProKidney has a beta of […] ....
Jonas Reinold and colleagues investigate how isotretinoin use has changed over a 15 year period in Germany and the potential for in-utero exposure. ....
Social Capital Group LLC decreased its holdings in shares of ProKidney Corp. (NASDAQ:PROK – Free Report) by 12.8% during the 3rd quarter, Holdings Channel.com reports. The fund owned 11,573,000 shares of the company’s stock after selling 1,700,000 shares during the period. ProKidney makes up approximately 89.0% of Social Capital Group LLC’s portfolio, making the stock […] ....
The first report linking thalidomide to birth malformations was made by Australian doctor William McBride. The drug led to thousands of instances of pregnancy loss, neonatal deaths and disability. ....
ProKidney Corp. (NASDAQ:PROK) Major Shareholder Sells $138,299.00 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.